outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,723,758,1.0708880068,1.0708880068,1.0708880068,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.2926016197,0.0916418975,0.9342419806,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,550,4308,1.4625158428,0.554411706,3.8580581313,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,723,1218,1.9461198E-6,1.0542274E-6,3.5925667E-6,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3365,3768,0.1793397975,0.0615559318,0.5224965657,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,550,5619,0.5740790074,0.2332030359,1.4132179088,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,723,758,1.0723793761,0.7600210184,1.5131127933,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.3521478894,0.1023893968,1.2111423627,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,550,4308,2.6448633667,0.4285416441,16.323506304,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs No exposure,MPCD,723,1218,7.3273962E-7,3.4822133E-7,1.5418566E-6,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3365,3768,0.2045817691,0.0653219113,0.6407298784,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs No exposure,Medicare,550,5619,0.8658022023,0.2066005662,3.6283223586,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,723,758,1.1657107522,0.7484300724,1.815642647,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.3761889397,0.1079235012,1.3112817583,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,550,4308,2.7284089132,0.433191785,17.184571487,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,723,1218,5.8403659E-7,2.5835291E-7,1.3202821E-6,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3365,3768,0.1802944465,0.0567137146,0.5731609658,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,550,5619,0.8246641152,0.2069316275,3.2864522023,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,723,758,1.0098971193,0.7405021653,1.3772980546,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.3325523673,0.0977691049,1.1311454376,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,550,4308,2.2851488001,0.43722944,11.943168874,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,723,1218,7.1272985E-7,3.4083196E-7,1.4904231E-6,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3365,3768,0.205800156,0.0657333064,0.6443263928,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,550,5619,0.7517279801,0.2080029206,2.7167645269,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,723,758,1.0726894975,0.762114082,1.5098300703,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.3529186842,0.1028887993,1.2105457402,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,550,4308,2.7034179962,0.4869304816,15.009265465,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,723,1218,7.3133052E-7,3.4764815E-7,1.5384645E-6,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3365,3768,0.2037596112,0.0651321998,0.637441685,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,550,5619,0.8511386673,0.1870604332,3.8727432561,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,723,758,1.0688389226,0.6421621143,1.7790159481,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.3514694478,0.1027643015,1.2020786487,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,550,4308,2.4524363542,0.4829128585,12.454512166,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,723,1218,5.4269556E-7,2.4130884E-7,1.2205043E-6,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3365,3768,0.1811356853,0.0574313867,0.5712927791,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,550,5619,0.7246311162,0.1830118903,2.8691592319,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,723,758,1.1314404384,0.6800210086,1.8825263475,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3365,3452,0.3666832977,0.1076616144,1.248881894,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,550,4308,2.6822737829,0.4079934788,17.634087358,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,723,1218,1.5011805E-7,6.4802958E-8,3.4775308E-7,0,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3365,3768,0.1768118849,0.0554266343,0.564032852,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,550,5619,0.8186563811,0.2133963028,3.1406273756,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,1.27568315,0.346295195,4.6993649423,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.071276223,0.4993657378,2.2981807903,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4351,0.6771735418,0.4444789679,1.0316888737,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,724,1218,1.3732247273,0.6226504828,3.0285789602,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3370,3769,0.9543477861,0.5748996587,1.5842411508,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,551,5623,2.4336125222,1.6389165814,3.6136493922,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,1.6590725927,0.2861877299,9.6178891696,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.2948484356,0.5802029315,2.8897345743,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4351,0.676695259,0.3762412995,1.2170818943,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs No exposure,MPCD,724,1218,1.7267540683,0.4078224332,7.3112202015,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3370,3769,1.0882718286,0.6137286377,1.9297381612,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs No exposure,Medicare,551,5623,2.4667803824,1.5251501675,3.9897746364,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,1.6841161618,0.3065934102,9.2508421657,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.3300515993,0.5929330109,2.9835364612,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4351,0.7012438694,0.3902618773,1.2600333083,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,1.5908864337,0.4161072722,6.0823730177,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3370,3769,1.0509337293,0.5899998608,1.8719694304,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,2.4632974506,1.5276088921,3.9721124705,1,1
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,724,758,1.564956007,0.2534852708,9.6616552748,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.2486255011,0.5604110868,2.7820035663,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,551,4351,0.5956878798,0.3364269879,1.0547431178,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,724,1218,1.6076055606,0.3497462207,7.389345433,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3370,3769,1.0851716817,0.6122190193,1.9234906816,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,551,5623,2.1349968541,1.3208185089,3.451050645,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,1.6373142739,0.2842100894,9.4324520168,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.3226951839,0.5893582718,2.9685212427,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4351,0.8169661075,0.3946833028,1.691061203,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,724,1218,1.7272277155,0.4095264027,7.2847942449,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3370,3769,1.0664345412,0.5986389048,1.8997806884,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,551,5623,2.2754526746,1.3976261818,3.704627848,1,1
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,1.5956170163,0.2713818278,9.3815922893,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.3053917202,0.5818914961,2.9284627023,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4351,0.7466907245,0.3692009166,1.5101453246,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,724,1218,1.4857856601,0.3547129739,6.2235079915,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3370,3769,1.0294125959,0.5753690786,1.8417574597,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,551,5623,1.9475710649,1.1881654818,3.1923440891,1,1
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,1.3940291005,0.3264323756,5.9531997389,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3370,3464,1.2697633004,0.5626738348,2.8654235178,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4351,0.6711661353,0.3633286295,1.2398251736,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,1.4167611884,0.4943784335,4.0600724649,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3370,3769,1.1166269531,0.6178932346,2.0179145565,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,2.6442354945,1.6424193542,4.2571230863,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,714,745,0.5486859884,0.2211083972,1.3615779306,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3337,3381,0.8033661372,0.5314084988,1.2145028764,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,507,3845,1.4769462289,1.0401589914,2.097150706,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,714,1215,0.2017703517,0.0968382422,0.4204049339,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3337,3763,0.3816923759,0.2727555591,0.5341378568,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,507,5596,0.5649299212,0.4087069526,0.7808671074,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,714,745,0.5859783569,0.1631102331,2.105144651,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3337,3381,1.1090742501,0.688321735,1.7870214317,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,507,3845,1.8285194507,1.1484135776,2.9113931137,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs No exposure,MPCD,714,1215,0.1803844732,0.056926597,0.5715879726,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3337,3763,0.4968441506,0.3320710167,0.7433774631,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs No exposure,Medicare,507,5596,0.7407507161,0.4856578867,1.1298315922,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,714,745,0.577372939,0.1595703362,2.0891070266,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3337,3381,1.0879218333,0.6751631568,1.7530191088,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,507,3845,1.8209160414,1.1465110377,2.8920220744,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,714,1215,0.193355904,0.0612147397,0.6107435198,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3337,3763,0.5147145188,0.3436490987,0.7709347612,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,507,5596,0.7555953337,0.4916946116,1.1611359873,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,714,745,0.5634213602,0.1561538739,2.0328898748,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3337,3381,1.0648665232,0.6598228614,1.7185532339,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,507,3845,1.6265432477,1.0274572296,2.5749421586,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,714,1215,0.1766192777,0.0555786668,0.5612651595,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3337,3763,0.4987247542,0.3332531266,0.7463587303,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,507,5596,0.6643586531,0.4391707985,1.0050131326,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,714,745,0.5849448907,0.1628212203,2.1014492123,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3337,3381,1.101914042,0.6839548956,1.7752845455,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,507,3845,1.7024324329,1.0781076715,2.6882993834,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,714,1215,0.1805161923,0.0569656372,0.5720307419,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3337,3763,0.5016969043,0.3352986218,0.7506734816,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,507,5596,0.7685052495,0.5019008524,1.1767270679,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,714,745,0.5492104985,0.1508071173,2.000118941,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3337,3381,1.042401144,0.6460160628,1.6820017453,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,507,3845,1.5183398237,0.9684009607,2.3805798566,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,714,1215,0.1856572318,0.0584960459,0.589246797,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3337,3763,0.5165303345,0.3447123879,0.7739889712,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,507,5596,0.6959445766,0.4554738108,1.0633736609,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,714,745,0.5606822865,0.1510983905,2.0805292846,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3337,3381,1.0649195265,0.658105781,1.7232086856,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,507,3845,1.7429484112,1.0815606355,2.8087830348,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,714,1215,0.1923334692,0.0622030805,0.5946998614,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3337,3763,0.5166435496,0.3433225742,0.7774628799,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,507,5596,0.801202725,0.5204463929,1.2334138834,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,718,755,0.928732273,0.2077449231,4.1519360483,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.772015953,0.7876229965,3.9867303919,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,520,4075,1.4047645215,0.9007869315,2.1907104689,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,718,1217,0.3221230367,0.1109451273,0.9352664084,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3355,3765,0.5731165477,0.3382213533,0.9711467772,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,520,5616,0.6396745691,0.4241212215,0.9647797222,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,718,755,0.4749358716,0.0943754861,2.3900706801,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.679727231,0.6843449371,4.1228968281,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,520,4075,1.4932015989,0.8138490925,2.7396369125,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs No exposure,MPCD,718,1217,0.1941853,0.0574666908,0.6561702124,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3355,3765,0.6510834764,0.3544116211,1.1960942251,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs No exposure,Medicare,520,5616,0.8178013274,0.4634669603,1.4430349267,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,718,755,0.4782379515,0.0948239705,2.4119590973,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.666780311,0.6789875037,4.091616694,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,520,4075,1.4873151771,0.8136901837,2.7186102035,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,718,1217,0.2030645776,0.0599815508,0.6874650979,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3355,3765,0.6619032245,0.3588091045,1.2210277642,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,520,5616,0.8249464394,0.4634942411,1.4682741824,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,718,755,0.467643412,0.0924154739,2.366382507,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.6590110557,0.6742417952,4.0820929561,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,520,4075,1.4448753812,0.752133758,2.7756563844,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,718,1217,0.1915228362,0.0565473382,0.648677691,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3355,3765,0.6509025731,0.3545142375,1.1950836237,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,520,5616,0.7896429425,0.437901793,1.4239173867,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,718,755,0.4749477151,0.0943784639,2.390114469,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.678565053,0.684240222,4.1178237508,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,520,4075,1.4824041617,0.815735189,2.6939160259,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,718,1217,0.1941881221,0.0574678641,0.6561758883,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3355,3765,0.6517941232,0.3548006857,1.1973922152,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,520,5616,0.8213133153,0.4607764753,1.4639539951,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,718,755,0.4704516752,0.0926652384,2.3884337046,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.6486215585,0.670379113,4.0543522173,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,520,4075,1.4395408764,0.7570793417,2.7372004762,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,718,1217,0.1995908536,0.0587075849,0.6785581274,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3355,3765,0.6607671372,0.3584582584,1.2180308287,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,520,5616,0.7987209648,0.4315733755,1.4782079153,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,718,755,0.4353670515,0.0847520637,2.2364584563,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3355,3435,1.5701334729,0.6414726692,3.8432177099,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,520,4075,1.3699068735,0.7203663542,2.6051256159,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,718,1217,0.2134377039,0.0627432657,0.7260644298,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3355,3765,0.6966585695,0.3680257869,1.3187477067,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,520,5616,0.9198422521,0.5242542804,1.6139301105,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,723,757,9.0854418E-6,2.2518767E-6,0.0000366562,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3357,3437,0.7638263784,0.3627977491,1.6081432086,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,530,4156,1.0452703414,0.6372188538,1.7146229747,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,723,1218,3.710669E-6,2.1990793E-6,6.2612861E-6,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3357,3769,0.3764251729,0.2117885533,0.669044236,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,530,5623,0.7282094307,0.4598771961,1.1531099595,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,723,757,3.4092679E-6,8.1359893E-7,0.000014286,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3357,3437,1.1950409112,0.4803768857,2.9729215159,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,530,4156,1.2524719939,0.6386701708,2.4561756088,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs No exposure,MPCD,723,1218,1.4192184E-6,7.860092E-7,2.5625409E-6,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3357,3769,0.5465779281,0.2463044757,1.2129192157,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs No exposure,Medicare,530,5623,0.9868294274,0.531677414,1.8316225087,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,723,757,3.4610093E-6,8.217513E-7,0.0000145769,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3357,3437,1.2332238097,0.4936611567,3.080738568,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,530,4156,1.2923553858,0.6557347913,2.5470395432,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,723,1218,1.2442895E-6,6.7288675E-7,2.3009167E-6,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3357,3769,0.5179851475,0.2308827287,1.1620991077,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,530,5623,0.982498845,0.5232537407,1.8448104719,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,723,757,3.2884648E-6,7.7726627E-7,0.0000139129,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3357,3437,1.1671597782,0.4678067707,2.9120184512,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,530,4156,1.173442709,0.5740298354,2.3987739074,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,723,1218,1.3758518E-6,7.5798761E-7,2.4973602E-6,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3357,3769,0.5469672999,0.246855704,1.2119356461,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,530,5623,0.9203163874,0.4843118812,1.7488364125,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,723,757,3.4063349E-6,8.1262715E-7,0.0000142785,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3357,3437,1.1929115076,0.4796017067,2.9671242722,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,530,4156,1.2269866651,0.6405572741,2.3502914373,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,723,1218,1.4174494E-6,7.8434475E-7,2.5615814E-6,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3357,3769,0.5480304234,0.2470026332,1.2159277054,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,530,5623,0.9968011887,0.5317931484,1.8684193521,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,723,757,3.3448068E-6,7.910812E-7,0.0000141423,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3357,3437,1.2010450732,0.4797241639,3.0069556141,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,530,4156,1.188413611,0.5971789452,2.3649978323,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,723,1218,1.1811201E-6,6.4527341E-7,2.1619435E-6,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3357,3769,0.5189811514,0.2317663003,1.1621251024,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,530,5623,0.9274830025,0.4805131402,1.7902210115,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,723,757,1.099349E-6,2.5340311E-7,4.7693504E-6,0,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3357,3437,1.1471861692,0.4806900929,2.7378057632,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,530,4156,1.1557998779,0.5503870923,2.4271524105,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,723,1218,4.6562466E-7,2.4069975E-7,9.0073345E-7,0,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3357,3769,0.5569167276,0.2305589029,1.3452364561,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,530,5623,1.170013638,0.6220902716,2.2005357996,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,723,758,1.0566726851,0.8862254189,1.259901984,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.4515606303,0.2968910326,7.0969750929,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,545,4293,0.7655070773,0.3867354577,1.5152504738,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,723,1218,0.0000214108,3.0054556E-6,0.0001525306,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3367,3768,0.4888380613,0.1857696978,1.2863381541,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,545,5623,1.0670474649,0.5606563706,2.0308166501,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,723,758,1.0939165644,0.7277579794,1.6443013799,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.7662118314,0.3434834301,9.0819642524,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,545,4293,0.7848594468,0.3402157589,1.8106285063,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs No exposure,MPCD,723,1218,8.7079484E-6,1.1956887E-6,0.0000634181,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3367,3768,0.4836006287,0.1714619315,1.3639737173,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs No exposure,Medicare,545,5623,1.0105242687,0.461633755,2.2120550902,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,723,758,1.092672349,0.7262762002,1.643910212,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.8547311367,0.360109189,9.5527348225,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,545,4293,0.8236835539,0.3548416705,1.9119924559,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,723,1218,6.7063994E-6,9.1442896E-7,0.0000491846,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3367,3768,0.4417474322,0.154949088,1.2593865278,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,545,5623,0.9756589114,0.4435227453,2.1462491416,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,723,758,1.0503885938,0.6762955963,1.6314111818,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.7193165962,0.3346423613,8.8334589398,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,545,4293,0.73211168,0.2990406006,1.7923569941,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,723,1218,8.3932611E-6,1.1493811E-6,0.0000612911,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3367,3768,0.4831294675,0.1713974881,1.3618290736,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,545,5623,0.9359712906,0.4120426651,2.1260959872,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,723,758,1.1175128971,0.7429695499,1.6808697952,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.7841282796,0.3465267607,9.1857659468,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,545,4293,0.8573901412,0.3674679617,2.0004950932,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,723,1218,7.6111063E-6,1.0450947E-6,0.0000554294,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3367,3768,0.4771368582,0.168894314,1.3479410649,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,545,5623,0.9511145603,0.4180718825,2.1637879625,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,723,758,1.055265413,0.6857726575,1.6238400289,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.8149506657,0.3521464968,9.3541919316,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,545,4293,0.8415165734,0.3479507848,2.0352020295,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,723,1218,5.4115339E-6,7.4177044E-7,0.0000394795,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3367,3768,0.435703777,0.1527466843,1.24282751,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,545,5623,0.8566871333,0.3657248519,2.0067349552,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,723,758,1.0872167866,0.6752913846,1.7504152548,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3367,3459,1.7910409534,0.3571607033,8.9814687546,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,545,4293,0.810584589,0.340726881,1.9283696488,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,723,1218,1.1499048E-6,1.5503192E-7,8.529089E-6,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3367,3768,0.4380701732,0.150834718,1.2722898226,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,545,5623,0.9703573535,0.432408288,2.1775563039,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,0.9064779338,0.3925552741,2.0932141247,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.7040458052,0.5500789452,0.901107923,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4351,0.5818998315,0.4627051255,0.7317995745,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,724,1218,0.7102555192,0.415061992,1.2153917057,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3370,3769,1.1372593088,0.9288528796,1.392425823,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,551,5623,2.4273144501,1.9496586648,3.0219933089,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,0.8192832513,0.249690531,2.6882278765,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.6399656352,0.4789131345,0.8551780785,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4351,0.639831947,0.4711512097,0.8689034686,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs No exposure,MPCD,724,1218,0.6332194006,0.2332311011,1.7191824222,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3370,3769,1.0939538302,0.8625195718,1.3874873355,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs No exposure,Medicare,551,5623,2.3872942865,1.7908168102,3.1824438871,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,0.8383102047,0.254682621,2.7593716311,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.6645114813,0.4965380377,0.8893085227,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4351,0.6631569844,0.4915618683,0.8946527678,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,0.5730188382,0.2082546951,1.5766779656,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3370,3769,1.0361517267,0.8152675315,1.3168810965,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,2.3497218227,1.7705538268,3.1183421597,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,724,758,0.8504740135,0.2574012516,2.810033141,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.6542251062,0.4885584457,0.8760681416,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,551,4351,0.6831770619,0.5002733121,0.9329518216,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,724,1218,0.6609958742,0.2416964323,1.8077037445,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3370,3769,1.096410777,0.8641254275,1.3911366956,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,551,5623,2.5782276646,1.921197587,3.459955361,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,0.8152449998,0.2487589027,2.6717613017,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.6492010954,0.4855470599,0.868014858,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4351,0.722178284,0.5425374276,0.9613004512,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,724,1218,0.6335117375,0.2334534658,1.7191311351,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3370,3769,1.0763025488,0.8482671824,1.3656395066,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,551,5623,2.2122282778,1.6397309892,2.9846078322,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,0.8459983514,0.2556444085,2.7996435156,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.683763683,0.5091612015,0.9182411638,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4351,0.7626951157,0.5724994812,1.0160774962,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,724,1218,0.5967416075,0.2156212251,1.6515097057,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3370,3769,1.0280190739,0.8081200206,1.3077552707,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,551,5623,2.3109411041,1.7081763272,3.1264036983,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,0.7767756671,0.2381187663,2.5339474339,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.6267427283,0.4702431613,0.8353262309,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4351,0.6376735997,0.4661118239,0.8723821172,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,0.581079042,0.2074468615,1.627659491,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3370,3769,1.068025589,0.8342716544,1.3672748591,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,2.4027028941,1.8080687036,3.1928992442,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,1.2907354549,0.3883395629,4.2900548229,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.9214548288,0.5679404858,1.4950140425,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4351,1.0677829702,0.6654190608,1.7134472674,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,724,1218,1.9683011187,0.7367667598,5.258393165,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3370,3769,1.143416774,0.7368305542,1.7743589914,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,551,5623,1.2164167531,0.7775700921,1.9029406253,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,0.7546903768,0.179680423,3.1698365093,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.8431387567,0.4760794087,1.4932024996,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4351,0.9125332065,0.5283954764,1.5759348636,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs No exposure,MPCD,724,1218,1.495128411,0.4616872084,4.841825645,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3370,3769,1.1746087816,0.6829264999,2.0202844523,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs No exposure,Medicare,551,5623,1.3446600379,0.7248368326,2.4945070894,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,0.7757738086,0.1847469896,3.2575632406,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.869988542,0.4883705715,1.5498068628,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4351,0.9636456191,0.5612940722,1.6544141923,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,1.3633748015,0.4157134278,4.4713274219,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3370,3769,1.0919281574,0.6345644393,1.8789377831,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,1.3565110055,0.7285913686,2.5255886734,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,724,758,0.8346330759,0.1983237247,3.5125014533,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.894152992,0.5056707368,1.5810872865,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,551,4351,1.0846347384,0.61583088,1.910317514,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,724,1218,1.6518663058,0.5067897316,5.3842099041,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3370,3769,1.1790293352,0.687289355,2.022598143,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,551,5623,1.6541561436,0.8574467469,3.1911399249,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,0.7547886597,0.1796889724,3.1705113189,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.8455517573,0.4774053862,1.4975905068,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4351,0.9367446161,0.551789848,1.590262088,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,724,1218,1.490015439,0.4607413674,4.8186383196,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3370,3769,1.170047721,0.6801555504,2.0127920276,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,551,5623,1.3243481396,0.7044630655,2.489694749,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,0.8397364243,0.198698988,3.5488719373,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.9221413709,0.5173621658,1.6436159505,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4351,1.1031869588,0.6447523149,1.8875798317,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,724,1218,1.5485749663,0.4636436364,5.1722578252,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3370,3769,1.104657236,0.643281976,1.8969404622,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,551,5623,1.612678461,0.8218651016,3.1644266359,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,0.7426291701,0.1779724818,3.0987829049,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3370,3464,0.8400831682,0.477589728,1.4777112823,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4351,0.8872935251,0.4943493318,1.5925778573,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,1.412454819,0.4200112406,4.7499410084,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3370,3769,1.1696110911,0.6590865097,2.0755850472,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,1.5365113585,0.8406782703,2.8082885431,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,670,741,1.8313330282,0.7044560247,4.7608091099,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.5662013173,1.0335616361,2.3733336074,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,511,4221,2.9457014097,1.5934187409,5.4456224043,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,670,1206,0.7716944776,0.4141401675,1.437948824,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3163,3706,0.544903446,0.4105298203,0.7232599211,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,511,5592,1.1806222955,0.6948503772,2.0059987738,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,670,741,3.0401137302,0.8448706215,10.939297992,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.3273201019,0.8114203594,2.1712280602,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,511,4221,4.4515251911,2.1072228299,9.4038828007,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"a Weighted, no covariates",TNF vs No exposure,MPCD,670,1206,1.1878620327,0.403342784,3.4983053241,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3163,3706,0.5672490817,0.4103349454,0.7841679688,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"a Weighted, no covariates",TNF vs No exposure,Medicare,511,5592,1.8311806582,0.9712099858,3.452623688,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,670,741,3.0104259355,0.8343393372,10.862084417,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.3032787235,0.7963383198,2.1329319321,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,511,4221,4.4436981319,2.1187462725,9.3198762609,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,670,1206,1.246258073,0.4109375195,3.7795506881,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3163,3706,0.5779810082,0.4165823432,0.801911198,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,511,5592,1.8495762318,0.9710462324,3.5229344628,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,670,741,3.0476584253,0.8525301107,10.894890116,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.3302697727,0.8068572714,2.1932226811,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,511,4221,4.4757671015,2.0587591039,9.7303716151,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,670,1206,1.1901490703,0.407183065,3.4786682733,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3163,3706,0.5672182913,0.4103280873,0.7840959464,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,511,5592,1.8416970711,0.9493543049,3.5727947769,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,670,741,3.0424487205,0.8452490103,10.95120385,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.3198791462,0.8066392931,2.1596777833,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,511,4221,4.1991779149,2.0196310459,8.7308497246,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,670,1206,1.1883949963,0.4035151114,3.4999498838,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3163,3706,0.5717416644,0.4138337455,0.7899030331,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,511,5592,1.8945838075,0.9950871147,3.6071694133,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,670,741,3.0343643122,0.8472538673,10.867305698,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.3042623232,0.7904303093,2.1521191532,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,511,4221,4.2338288052,1.9763527822,9.069892032,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,670,1206,1.2535759952,0.4177874917,3.7613686554,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3163,3706,0.5826657937,0.4200410737,0.8082529265,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,511,5592,1.9338590124,0.9698513176,3.8560659886,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,670,741,2.9712137589,0.8494672233,10.392527173,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3163,3356,1.2705147247,0.7785004136,2.0734833758,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,511,4221,4.3475605594,2.0689285184,9.1357834018,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,670,1206,1.2667990888,0.4084903549,3.9285626018,1,0
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3163,3706,0.5795185522,0.4183919791,0.8026964404,1,1
Inflammatory bowel disease,Crohns disease or ulcerative colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,511,5592,1.8435421367,0.9674414693,3.5130265939,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,722,756,1.3191098668,0.1113032992,15.633416564,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3369,3464,2591719.867,816238.06497,8229231.3445,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,550,4340,5.19639924,0.343142555,78.691974137,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,722,1218,7431650.8298,1901324.9302,29047867.188,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3369,3769,0.7447788747,0.169352199,3.2753963355,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,550,5623,1.8459480645,0.2226698538,15.303033609,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,722,756,1.3092316187,0.1056493447,16.224307264,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3369,3464,873604.7263,240794.65068,3169444.2367,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,550,4340,0.9293539672,0.0622566493,13.873197589,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs No exposure,MPCD,722,1218,2602756.8895,589997.4564,11481987.511,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3369,3769,0.5763643372,0.1141372238,2.9104952635,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs No exposure,Medicare,550,5623,0.3086218211,0.0363151367,2.6228024218,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,722,756,1.4314772296,0.1138993766,17.990678441,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3369,3464,2153175.0921,605217.02788,7660331.3583,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,550,4340,0.9377248103,0.0615360806,14.289629944,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,722,1218,8670004.4503,1833375.1019,41000326.169,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3369,3769,0.5747126462,0.1085425234,3.0429974857,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,550,5623,0.3022195262,0.0362671993,2.5184365963,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,722,756,1.2407691251,0.1008349542,15.267602729,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3369,3464,816974.20081,229612.67506,2906837.981,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,550,4340,0.7842153981,0.0486750848,12.634673232,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,722,1218,2461310.7314,566149.86033,10700436.3,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3369,3769,0.5773042022,0.114144836,2.9198004349,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,550,5623,0.2583594682,0.0270112002,2.4711828496,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,722,756,1.3207178871,0.1061964872,16.425173599,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3369,3464,881746.59913,242476.11532,3206406.8002,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,550,4340,1.2261380416,0.1037338627,14.49299639,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,722,1218,2680434.3641,607985.07701,11817277.516,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3369,3769,0.5353614329,0.1043444816,2.7467850665,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,550,5623,0.2277138724,0.0173765958,2.9841062211,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,722,756,1.3523571748,0.1079924859,16.935159085,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3369,3464,1961898.0036,549869.02605,6999928.336,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,550,4340,1.1968370191,0.1032435147,13.874177513,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,722,1218,9076197.6132,1994214.1738,41308182.539,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3369,3769,0.5258809509,0.0979012079,2.824794306,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,550,5623,0.1937559289,0.0147033349,2.553254778,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,722,756,1.5559813398,0.1262044444,19.183777099,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3369,3464,2416236.0262,682299.09976,8556652.847,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,550,4340,1.006211161,0.0628935018,16.098020795,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,722,1218,8460166.855,1816040.9042,39412340.905,0,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3369,3769,0.562477686,0.106150401,2.9804988434,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,550,5623,0.2523485484,0.0318856451,1.997130359,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,48596349.4,10846805.533,217723565.51,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3369,3464,5559864.0954,703991.3053,43909759.292,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4347,25248235.382,3495792.0029,182354496.32,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,724,1218,33209468.176,8425667.3947,130893936.93,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3369,3769,0.9088362643,0.0583148856,14.164194052,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,551,5623,1.6786214558,0.2064350574,13.649667974,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,4165672.599,906687.60627,19138706.741,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3369,3464,158128.02262,21977.905952,1137709.4612,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,551,4347,9720556.9646,1421212.8512,66484923.51,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs No exposure,MPCD,724,1218,4128617.2335,947047.46276,17998549.102,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3369,3769,0.4179261556,0.0262106976,6.663778055,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs No exposure,Medicare,551,5623,6.1003484561,0.8271007108,44.99361541,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,4108102.8884,877074.65319,19241816.281,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3369,3464,146513.29552,20422.200723,1051118.1461,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4347,9480667.1629,1398097.1032,64289561.611,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,5971333.3819,1378332.0925,25869543.741,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3369,3769,0.4666307939,0.0291509418,7.4695459072,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,6.5063064426,0.8597661994,49.236668706,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,724,758,4375919.7799,944831.94732,20266751.114,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3369,3464,171148.66109,23907.305699,1225226.4877,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,551,4347,12056993.887,1571214.3698,92521494.452,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,724,1218,4156728.9405,939079.98582,18399279.876,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3369,3769,0.4125165239,0.0258676283,6.5784879941,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,551,5623,7.1370866495,0.8784826987,57.984074039,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,4481805.3506,975211.8609,20597144.073,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3369,3464,165008.08302,22931.854909,1187329.4843,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4347,8303629.9157,1211987.7953,56890234.408,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,724,1218,4487619.16,1029325.6531,19564970.198,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3369,3769,0.4249452239,0.0266430481,6.7776946066,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,551,5623,6.6054471115,0.8945674825,48.774332173,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,14589940.004,3321304.2259,64091192.748,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3369,3464,451752.02777,62997.327504,3239500.8278,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,551,4347,29748374.044,3700914.4086,239120838.95,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,724,1218,20460061.865,4899934.5993,85432595.692,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3369,3769,0.4766228637,0.0298636968,7.6068731871,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,551,5623,8.9797532015,1.0228584418,78.833946388,1,1
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,6188987.875,1218495.7205,31435129.62,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3369,3464,352214.40921,48483.851041,2558686.8079,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,551,4347,14139152.639,2263573.1689,88318610.637,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,7899223.4117,1795217.5759,34757753.793,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3369,3769,0.4597088213,0.0287209831,7.358111648,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,551,5623,6.4136115265,0.8333686985,49.359200662,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,1.1002283289,0.9038834499,1.3392239628,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3369,3463,862552.03845,119680.02232,6216543.1173,0,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,545,4321,2.4288229147,0.60916922,9.6839770584,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,724,1218,0.9091560937,0.787312545,1.0498560044,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3369,3769,0.2448417473,0.0274888514,2.1807925062,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,545,5623,1.3740662961,0.4122338781,4.5800655562,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,758,1.0646638228,0.7044176893,1.6091433717,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3369,3463,533030.65103,68051.14646,4175119.5933,0,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,545,4321,2.1501645515,0.450723481,10.257303632,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs No exposure,MPCD,724,1218,0.9842216924,0.7476146992,1.2957106661,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3369,3769,0.5625358818,0.0637183089,4.966337366,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs No exposure,Medicare,545,5623,1.2685537963,0.272610617,5.9030303078,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,1.1401044419,0.7846395627,1.6566054022,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3369,3463,575137.90368,75615.177158,4374566.3329,0,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,545,4321,2.2305032923,0.4635338814,10.733077207,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,0.7861848508,0.5172949436,1.1948437294,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3369,3769,0.4746012329,0.0510207972,4.4147944087,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,545,5623,1.172617491,0.2709615891,5.0746372753,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,724,758,1.1630510609,0.80837044,1.6733513538,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3369,3463,569420.91173,73083.503812,4436571.2891,0,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,545,4321,2.4761890064,0.4789122396,12.802997059,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,724,1218,1.064257472,0.7568611687,1.4965016221,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3369,3769,0.5620735682,0.063725998,4.9575794199,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,545,5623,1.4748047075,0.2818202084,7.7178600427,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,1.0646297778,0.704410178,1.609057619,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3369,3463,534297.92702,68156.355232,4188520.2613,0,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,545,4321,2.1812760756,0.487878356,9.7523599061,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,724,1218,0.9840673778,0.747410295,1.2956586368,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3369,3769,0.5612047397,0.0635143518,4.9587337493,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,545,5623,1.2554540142,0.2515376634,6.266118403,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,724,758,1.22587201,0.7828350821,1.9196408275,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3369,3463,616813.58822,81044.091352,4694469.3471,0,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,545,4321,2.403983806,0.5200754264,11.112115371,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,724,1218,0.8483302721,0.5388374404,1.3355869446,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3369,3769,0.476193176,0.0512092433,4.4281056739,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,545,5623,1.2945504683,0.2631260691,6.3690417328,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,758,1.1490762114,0.7825415613,1.6872920302,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3369,3463,2910204.3161,358063.8365,23653014.626,0,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,545,4321,2.349632659,0.4988460094,11.067089899,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1218,0.8662637217,0.5168123588,1.4520024971,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3369,3769,0.4729703071,0.0476626873,4.693417934,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,545,5623,1.0615087257,0.2387191659,4.7201940018,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,718,757,0.1743358468,0.0195490216,1.5547063201,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.6896968029,0.7492757023,3.8104469116,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,531,4194,1.1345392089,0.6264060315,2.0548640209,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,718,1217,0.1527714475,0.0198744136,1.1743297528,1,0
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3352,3769,0.5403713986,0.3164036688,0.9228756718,1,1
Lung disease,Restrictive lung disease,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,531,5621,0.7943639677,0.4525847619,1.3942451587,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,718,757,1.4837725055,0.1849594242,11.903047693,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.7902647443,0.7731808804,4.1452756214,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,531,4194,0.6477279151,0.3149752227,1.3320141449,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs No exposure,MPCD,718,1217,2.0038745742,0.2693981367,14.905497706,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3352,3769,0.6051015236,0.3401709904,1.0763641353,1,0
Lung disease,Restrictive lung disease,"a Weighted, no covariates",TNF vs No exposure,Medicare,531,5621,0.5933957434,0.3025853959,1.1636996134,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,718,757,1.4907340348,0.1850411827,12.009693895,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.8197641695,0.7837981843,4.2249927325,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,531,4194,0.6543277854,0.3160155972,1.3548218963,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,718,1217,1.8679982071,0.2340803796,14.906919188,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3352,3769,0.5884488277,0.3276933239,1.0566953843,1,0
Lung disease,Restrictive lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,531,5621,0.5887533213,0.3011257275,1.1511154369,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,718,757,1.4442545972,0.1849856476,11.275855009,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.748151973,0.7544790293,4.0505238743,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,531,4194,0.6129653381,0.30152849,1.2460729851,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,718,1217,1.9564573938,0.2711879516,14.114659266,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3352,3769,0.6053976451,0.3404057615,1.0766748103,1,0
Lung disease,Restrictive lung disease,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,531,5621,0.5592598435,0.2918539205,1.0716716497,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,718,757,1.4838120423,0.1849618284,11.903527315,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.7894190761,0.7729230692,4.1427417002,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,531,4194,0.6451498869,0.3192920681,1.3035662899,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,718,1217,2.0038955145,0.269403146,14.905532074,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3352,3769,0.6054125652,0.3403464377,1.076915559,1,0
Lung disease,Restrictive lung disease,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,531,5621,0.5951057618,0.2991183796,1.183982302,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,718,757,1.4634754143,0.1860813904,11.509803771,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.7807384969,0.7658200965,4.1406978074,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,531,4194,0.6168703631,0.3061979523,1.2427550284,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,718,1217,1.8190712011,0.2363126089,14.002723133,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3352,3769,0.5879510621,0.3277216668,1.0548172016,1,0
Lung disease,Restrictive lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,531,5621,0.5547577846,0.2869118406,1.072650745,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,718,757,1.0844321334,0.1726074438,6.8131073974,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3352,3437,1.482228702,0.6144997031,3.5752693025,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,531,4194,0.5157480539,0.2274658022,1.1693892115,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,718,1217,2.0479026654,0.2579544209,16.258319249,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3352,3769,0.7002863141,0.3746668318,1.3088986801,1,0
Lung disease,Restrictive lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,531,5621,0.7714169854,0.388261517,1.5326890235,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,724,757,5.8476823E-7,7.9060206E-8,4.3252339E-6,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3367,3458,2.8623849905,0.3492260547,23.461158532,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,550,4344,0.1848915496,0.0235303679,1.4527985816,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs No exposure,MPCD,724,1217,1.0019827E-6,1.3721204E-7,7.3169186E-6,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3367,3769,4.156135328,0.6301454459,27.411863368,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs No exposure,Medicare,550,5623,0.2151392953,0.0313876134,1.4746236298,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,757,1.2222263E-6,1.665589E-7,8.9688213E-6,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3367,3458,2.8231568445,0.3530992053,22.572167962,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,550,4344,0.1861574294,0.0229971339,1.5069090212,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1217,2.1909992E-6,2.9996027E-7,0.0000160037,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3367,3769,4.2158807372,0.6109587763,29.091406949,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,550,5623,0.2134537491,0.032816315,1.3884100955,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,724,757,5.607331E-7,7.6667835E-8,4.101089E-6,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3367,3458,2.7630819696,0.3497727466,21.827378048,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,550,4344,0.1680393333,0.0199063112,1.4185057794,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,724,1217,9.7477152E-7,1.3402136E-7,7.0897616E-6,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3367,3769,4.1712839294,0.6303470529,27.603221973,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,550,5623,0.1958886903,0.0260531444,1.472850202,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,724,757,1.1773448E-6,1.5944538E-7,8.6935156E-6,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3367,3458,2.9626617829,0.3665303433,23.947171087,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,550,4344,0.2353834781,0.0216855269,2.5549474581,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,724,1217,2.0078929E-6,2.7546546E-7,0.0000146357,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3367,3769,3.9412919026,0.5836684703,26.614050017,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,550,5623,0.1734475962,0.0370452512,0.8120897453,1,1
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,724,757,7.0423527E-7,9.6863659E-8,5.1200556E-6,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3367,3458,2.8505848951,0.3679048168,22.08678406,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,550,4344,0.2255750871,0.0169475618,3.0024448617,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,724,1217,1.2811597E-6,1.7611772E-7,9.319733E-6,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3367,3769,4.0342935217,0.5728458009,28.411702055,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,550,5623,0.1596282982,0.0313830152,0.8119421752,1,1
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,724,757,2.2430374E-7,2.9549326E-8,1.7026502E-6,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3367,3458,3.0455502356,0.3622361652,25.605881266,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,550,4344,0.207091519,0.0247206918,1.7348582973,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,724,1217,3.9726731E-7,5.43293E-8,2.9049025E-6,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3367,3769,4.3513444925,0.6408963172,29.543310493,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,550,5623,0.2024723535,0.0304339853,1.3470156295,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,715,746,0.8964486601,0.3814032536,2.1070092938,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3338,3422,0.7402731126,0.4774608002,1.1477471681,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,514,3886,1.1033377132,0.7907128722,1.5395653114,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,715,1215,0.4834223863,0.2627443144,0.8894472337,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3338,3766,0.6349344145,0.4397584883,0.9167343471,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,514,5604,1.0035554636,0.7367052372,1.3670644888,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,715,746,0.5153303311,0.1874810851,1.4164914287,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3338,3422,1.0207066841,0.6130514555,1.6994366879,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,514,3886,1.1816300478,0.7520409329,1.8566137942,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs No exposure,MPCD,715,1215,0.3132949467,0.151588758,0.6475000184,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3338,3766,0.7804734778,0.4984306707,1.2221134962,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs No exposure,Medicare,514,5604,1.0675166176,0.7161731814,1.5912236851,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,715,746,0.5234594164,0.190334636,1.4396211132,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3338,3422,1.0308613614,0.6183880308,1.7184600823,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,514,3886,1.201724076,0.7683634711,1.8795020967,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,715,1215,0.3035080913,0.1465243602,0.6286815476,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3338,3766,0.7640601907,0.4879965017,1.1962954098,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,514,5604,1.0639324805,0.7128050961,1.5880250145,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,715,746,0.5327559011,0.1941205651,1.4621266431,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3338,3422,1.0494215212,0.6281835059,1.7531271019,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,514,3886,1.2646527169,0.7871087983,2.0319255709,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,715,1215,0.3233226091,0.1569051785,0.6662463954,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3338,3766,0.7819122299,0.4992693869,1.2245628338,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,514,5604,1.1517230173,0.7631251595,1.7382023015,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,715,746,0.5154297067,0.1875151046,1.4167807074,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3338,3422,1.022684072,0.6143372834,1.7024568414,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,514,3886,1.1980813478,0.7705582953,1.8628037941,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,715,1215,0.3132553813,0.1515699366,0.6474168701,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3338,3766,0.7785873856,0.4971467975,1.2193547661,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,514,5604,1.0581570443,0.7024231971,1.594048054,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,715,746,0.5370616176,0.1955320694,1.4751297936,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3338,3422,1.0561499216,0.6318341834,1.7654199255,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,514,3886,1.2846503144,0.8126127642,2.0308891306,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,715,1215,0.3154339801,0.1524990733,0.6524537734,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3338,3766,0.7677584611,0.4903011565,1.202226523,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,514,5604,1.1364094786,0.7429756257,1.7381815207,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,715,746,0.5050003642,0.1813206334,1.406488402,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3338,3422,0.9811702968,0.5946939761,1.618807639,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,514,3886,1.1622031356,0.7382614455,1.8295905018,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,715,1215,0.301926275,0.1459195781,0.6247240892,1,1
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3338,3766,0.7565853715,0.4838161686,1.1831382691,1,0
Osteoporotic fracture,Clinical vertebral or non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,514,5604,1.0493901333,0.6982835983,1.5770378319,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,670,726,1.5431713334,0.6679887965,3.5649965636,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.7497364047,1.2672524976,2.4159175,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,492,4116,3.0686879181,1.9436120061,4.8450233429,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,670,1194,0.9116121772,0.5105425154,1.6277523157,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3101,3694,1.4111303614,1.0843797424,1.8363390783,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,492,5572,2.0324143268,1.3631471569,3.0302729788,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,670,726,0.902035911,0.3531173789,2.3042445185,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.8530860823,1.2840624496,2.6742687083,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,492,4116,2.8119640665,1.6390995822,4.8240765827,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"a Weighted, no covariates",TNF vs No exposure,MPCD,670,1194,0.501510368,0.2459588298,1.0225802808,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3101,3694,1.3733719676,1.0175097998,1.8536927719,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"a Weighted, no covariates",TNF vs No exposure,Medicare,492,5572,1.6908107486,1.0755122796,2.658120267,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,670,726,0.8931639313,0.3473697015,2.2965209822,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.8495157074,1.282537649,2.6671406914,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,492,4116,2.8145509123,1.6427417165,4.8222412317,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,670,1194,0.4997633499,0.2422335387,1.0310851556,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3101,3694,1.3772146189,1.0137302028,1.8710304784,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,492,5572,1.6920102734,1.073246408,2.6675130184,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,670,726,0.9088809841,0.3558186853,2.3215887118,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.8662711071,1.2911658115,2.6975372288,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,492,4116,2.8633708426,1.6796992505,4.8811670183,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,670,1194,0.5051384731,0.2473727001,1.0314997451,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3101,3694,1.3729281934,1.0172892094,1.8528967051,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,492,5572,1.7232472683,1.0977291112,2.7052039683,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,670,726,0.9016351275,0.3529559197,2.3032505131,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.8464567628,1.2792510043,2.6651552865,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,492,4116,2.7330776756,1.596846041,4.6777919655,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,670,1194,0.5016092441,0.2460037845,1.0227965976,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3101,3694,1.3786938157,1.0211407647,1.8614442818,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,492,5572,1.7183573648,1.0839889506,2.7239687558,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,670,726,0.8989353219,0.3494931556,2.3121617688,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.8549568834,1.2836136015,2.6806081168,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,492,4116,2.7829556744,1.6358031503,4.7345808599,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,670,1194,0.5036624986,0.2437472512,1.0407334288,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3101,3694,1.3830133365,1.0173881373,1.8800355722,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,492,5572,1.7589964273,1.1081248277,2.7921659672,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,670,726,0.8424166377,0.3255912552,2.1796217811,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3101,3294,1.7662645783,1.2245965784,2.5475251326,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,492,4116,2.7170429001,1.5862237107,4.6540233078,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,670,1194,0.5114702089,0.2468562547,1.059733224,1,0
PsO/PsA,Psoriasis or psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3101,3694,1.4120359062,1.0367579786,1.9231541417,1,1
PsO/PsA,Psoriasis or psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,492,5572,1.7704353033,1.1161598009,2.8082369215,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,MPCD,683,728,1.3131967778,0.612217537,2.8167859837,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.4186304584,1.0050075073,2.0024849198,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD or NSAID,Medicare,525,4268,2.6515757035,1.4678173828,4.7900057554,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs No exposure,MPCD,683,1198,0.8944104246,0.5182486372,1.543602723,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs No exposure,Marketscan,3180,3704,0.8504765252,0.6548352601,1.104568376,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs No exposure,Medicare,525,5613,2.8706380656,1.6651207482,4.9489281258,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD or NSAID,MPCD,683,728,0.6107742376,0.2505072723,1.4891590407,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.180441537,0.8018019838,1.7378882198,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD or NSAID,Medicare,525,4268,2.7715538323,1.1990626447,6.4062629914,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs No exposure,MPCD,683,1198,0.4252197989,0.2090408674,0.8649594676,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs No exposure,Marketscan,3180,3704,0.7991796708,0.5927829201,1.0774401968,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs No exposure,Medicare,525,5613,3.3581349957,1.4915549003,7.5606138583,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,683,728,0.6307008155,0.2596585767,1.5319483137,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.2127414418,0.827831644,1.7766194556,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,525,4268,2.8275369176,1.2220301805,6.5423629857,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,683,1198,0.3844383898,0.1859957158,0.7946036547,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3180,3704,0.7574107497,0.5529132458,1.0375425947,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,525,5613,3.2977872848,1.4977497857,7.2611600949,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,MPCD,683,728,0.5835954711,0.2371601056,1.4360917617,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.1356845022,0.7656935936,1.6844587696,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD or NSAID,Medicare,525,4268,2.526145077,1.1470117311,5.5635080069,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs No exposure,MPCD,683,1198,0.4069083606,0.1979298939,0.8365306049,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs No exposure,Marketscan,3180,3704,0.7972940504,0.5913719508,1.0749204487,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs No exposure,Medicare,525,5613,3.0520297414,1.4239732522,6.541475079,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,MPCD,683,728,0.61077126,0.2505241413,1.4890442498,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.170139839,0.7949559707,1.7223938094,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD or NSAID,Medicare,525,4268,2.5430408323,1.1062192991,5.8460891793,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,MPCD,683,1198,0.425605631,0.2092239027,0.8657717919,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Marketscan,3180,3704,0.8095653633,0.6005350155,1.091353644,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs No exposure,Medicare,525,5613,3.5777354703,1.5864608414,8.0683939756,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,MPCD,683,728,0.6184282237,0.2540622553,1.5053533532,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.1583878518,0.7852902227,1.7087471312,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD or NSAID,Medicare,525,4268,2.3903675806,1.0814187042,5.2836677857,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,MPCD,683,1198,0.3639517099,0.1749589441,0.7570967454,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Marketscan,3180,3704,0.7594026006,0.5538708769,1.0412035257,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs No exposure,Medicare,525,5613,3.2035339367,1.5244238213,6.732136785,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,MPCD,683,728,0.6110770953,0.2517850594,1.4830713837,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Marketscan,3180,3330,1.1994285518,0.8253314447,1.7430922571,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs DMARD or NSAID,Medicare,525,4268,2.7720382233,1.1630481906,6.6069454155,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,MPCD,683,1198,0.4061326115,0.1960232365,0.8414497236,1,1
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Marketscan,3180,3704,0.7901933976,0.578592903,1.07917951,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)",TNF vs No exposure,Medicare,525,5613,3.4032355258,1.5249451485,7.5950351754,1,1
